International Collaboration: FDA and European Medicines Agency Agree to Accept a Single Orphan Drug Designation Annual Report

Voluntary move can save time, simplify development process

WHITE OAK, Md., Feb. 26 /PRNewswire-USNewswire/ -- In recognition of World Rare Disease Day, the U.S. Food and Drug Administration and the European Medicines Agency (EMA) today announced a more streamlined process to help regulators better i

http://digg.com/u1OR0C